Genetic engineering can be termed as the manipulation of genes of an organism or species for enhancing its abilities. The technology is used by pharmaceutical and biotechnology companies and by clinical research organizations. In medicine, gene therapy is the most widely used application for the treatment of cancer and other infectious diseases.
The extensive use of various technologies such as CRISPR/Cas9, TALEN, and ZNF in gene therapy for different genetic disorders and terminal illnesses is likely to be one of the primary drivers for the growth of this market.

Market Analysis and Insights: Global Genetic Engineering Market
The global Genetic Engineering market size is projected to reach US$ 5998.3 million by 2027, from US$ 3053.5 million in 2020, at a CAGR of 10.0% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Genetic Engineering market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Genetic Engineering market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Genetic Engineering market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Genetic Engineering market.

Global Genetic Engineering Scope and Market Size
Genetic Engineering market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Genetic Engineering market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Artificial Selection
Cloning
Gene Splicing
Others

Segment by Application
Agriculture
BT - Cotton
Golden Rice
Forensic Science
Medical
Recombinant Proteins
Recombinant Antibodies
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Thermo Fisher Scientific
GenScript
Amgen
Genentech
Merck
Horizon Discovery Group
Sangamo Therapeutics
Transposagen Biopharmaceuticals
OriGene Technologies